Batich, K., Mitchell, D., Healy, P., Herndon, J., Broadwater, G., Michael, G., … Sampson, J. (2021). CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA. In Neuro-Oncology (Vol. 23, pp. vi51–vi51). Hynes Convention Center, Boston, MA: Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noab196.202

Batich, Kristen, Duane Mitchell, Patrick Healy, James Herndon, Gloria Broadwater, Gunn Michael, Min-Nung Huang, et al. “CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA.” In Neuro-Oncology, 23:vi51–vi51. Oxford University Press (OUP), 2021. https://doi.org/10.1093/neuonc/noab196.202.

Batich K, Mitchell D, Healy P, Herndon J, Broadwater G, Michael G, et al. CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA. In: Neuro-Oncology. Oxford University Press (OUP); 2021. p. vi51–vi51.

Batich, Kristen, et al. “CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA.” Neuro-Oncology, vol. 23, no. Supplement_6, Oxford University Press (OUP), 2021, pp. vi51–vi51. Manual, doi:10.1093/neuonc/noab196.202.

Batich K, Mitchell D, Healy P, Herndon J, Broadwater G, Michael G, Huang M-N, Hotchkiss K, Sanchez-Perez L, Nair S, Congdon K, Norberg P, Weinhold K, Archer G, Reap E, Xie W, Shipes S, Albrecht E, Peters K, Randazzo D, Johnson M, Landi D, Desjardins A, Friedman H, Vlahovic G, Reardon D, Vredenburgh J, Bigner D, Khasraw M, McLendon R, Thompson E, Cook S, Fecci P, Codd P, Floyd S, Reitman Z, Kirkpatrick J, Friedman A, Ashley DM, Sampson J. CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA. Neuro-Oncology. Oxford University Press (OUP); 2021. p. vi51–vi51.